Information for Investors
- 100% of the capital is private.
- We are preparing a report to apply for European funds (H2020, SME Instrument) and also for Local funds (ENISA, CDTI, SODICAL, MADRID+D).
- Our research focuses on those diseases which currently do not have adequate treatments or for which there is no approved treatment.
- We are looking for investors who want to contribute to the project financially, but also with experience that will allow us to advance in the clinical research phases and regulatory strategies to obtain the registration for the pathologies of our investigations.